Citi analysts said in a note Monday that they believe history shows the dip in one major pharmaceutical company's shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE